We are a health technology company based in Finland and the United States. CardioSignal is a brand and a product by Precordior. CardioSignal is a CE marked class IIa medical device. The problem: Heart disease is the #1 killer in the world, accounting for over 20 million lives lost every year. Our solution: The digital cardiac biomarkers we are developing for several major heart diseases can replace invasive and costly standard care technologies, enabling faster care and with lower cost. Validated in clinical studies, with continuous focus on academic collaboration. CE marking indicates that a product has been assessed by the manufacturer and deemed to meet EU safety, health and environmental protection requirements. Provide your details, and we will contact you shortly.
Turku, Finland
Founded in 2016
11-50 Employees
Working industry
Medical
Type of company
-
Ownership structure
Privately Held
Locations
2 Locations
Specialised areas
Apps, Health Care, Medical
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
Finland
Overall risk estimation:
Very low
The ESG Data of countries are based on public sources
Environment
A
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
Precordior operates in 2 countries around the world
Get an overview of the locations of Precordior
Location
Country
State
City
Headquarter
Finland
South-Western Finland
Turku
United States Office
United States
California
Palo Alto
Some frequent questions that have been asked about Precordior
Where is Precordior located?
The company headquarter of Precordior is located in Turku, South-Western Finland, Finland. Precordior has subsidiaries in United States
How many employees does Precordior approximately have?
As of the latest available information Precordior has around 11-50 employees worldwide.
When was Precordior founded?
Precordior was founded in 2016
In which industries does Precordior mainly work?
The company Precordior has it's main focus in the industries of Medical
Check out some interesting alternative companies to Precordior
Cardiosense
Chicago, United States
1-10 Employees
2020
Cardiosense is building a digital biomarker platform that leverages novel, multi-sensor devices and proprietary algorithms to detect early signs of disease and guide personalized therapy. Built on over a decade of research, our team has developed an advanced signal processing pipeline to identify pre-symptomatic markers of cardiac disease. Device-agnostic software to enable aggregation, transmission, and analytics of physiological sensor data.
i-Virtual
Metz, France
11-50 Employees
2014
Our leading product, Caducy, is the first CE marked medical device for contactless measuring vital signs with a webcam. Caducy, is a CE Class IIa certified medical device that monitors vitals and provide a real-time health data. Our video-based solution delivers consistent results in just 30 seconds. This medical device is a regulated health product which carries the CE mark under this regulation.
Cardiaccs AS
Oslo, Norway
11-50 Employees
2009
Cardiaccs' smart lead has an integrated sensor for monitoring cardiac function. Cardiaccs' combined sensor and pace lead is placed and removed in the same way as standard temporary pace leads. Cardiaccs' lead has an embedded accelerometer sensor that measures the velocity of each cardiac contraction. Cardiaccs wants to cover the urgent unmet need for better cardiac monitoring to reduce morbidity and mortality in this patient group. Cardiaccs provides technology for measuring myocardial contractility, a vital parameter for monitoring of the cardiac function. Cardiaccs is ISO 13485 certified for the design, development and manufacture of active, non-implantable cardiac monitoring devices and associated software. This is a vital parameter for monitoring the cardiac function. The CS1 research product is suitable for animal trials and is NOT FOR HUMAN USE.
Heart Screen UK Ltd
London, United Kingdom
1-10 Employees
-
The mission behind our work at Heart Screen UK is to identify solutions which are proven to vastly improve the outcomes of large scale heart screening; and in turn, lead to accurate detection of coronary heart disease. Cardiosiography delivers highly accurate results, automatically to the health care practitioner, in fraction of the time of traditional methods. Cardisio GmbH, established in Frankfurt/Germany in 2016, is a privately held health company. Cardisio is a registered trademark of Cardisio GmbH in the United States.
CardiacSense Benelux
Bornem, Belgium
51-100 Employees
-
CardiacSense: de slimme, medisch gevalideerde wearable voor ambulante patiëntenmonitoring. CardiacSense: het nieuwe klinisch gevalideerde patiëntbewakingssysteem met CE-markering (MDR). CardiacSense is een medische en gevalideerde wearable met groot gebruiksgemak voor het thuismonitoren van een aantal vitale bio-parameters. Ook al oogt CardiacSense als een polshorloge, het gaat om een heel geavanceerd alles-in-één-apparaat dat continu de vitale waarden van de patiënt registreert. Hoewel CardiacSense de focus legt op het verzamelen van informatie in het kader van cardiologie, kan de wearable met diagnostische meerwaarde breder ingezet worden. Bovendien, CardiacSense laat toe data te laten aansluiten bij controlecentra zoals telezorgdiensten of een verpleegkundigenkamer binnen een bepaalde afdeling in een ziekenhuis of WZC.
CardiacSense
Hof HaCarmel Regional Council, Israel
11-50 Employees
2009
The highly accurate CardiacSense watch is a medical wearable device cleared by FDA and CE Marked. The CardiacSense watch is an enabler of big data analysis and AI backed healthcare since it provides 24/7/365 monitoring of vital signs. CardiacSense CEO Eldad Shemesh, a 20-year veteran of the Israeli Air Force, founded the company in 2012. The sophisticated, clinically proven CardiacSense cardiac and blood pressure monitoring device was developed by a team of leading physicians with expertise in electrophysiologists and hemodynamic and engineering experts in optics and electronics. The CardiacSense watch is a diagnostic device that helps the physician in taking life saving decisions. CardiacSense solution is a holistic solution that includes the sensors, the user application, the cloud application, and an integration capability to any EMR system. The expert multidisciplinary team at CardiacSense combines years of clinical, technical, and business experience. The level of accuracy of the clinical data that is received from the CardiacSense watch has no equivalent in wearable devices.
